• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Research in Oncology
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 20 (2024)
Volume Volume 19 (2023)
Volume Volume 18 (2022)
Issue Issue 2
Issue Issue 1
Volume Volume 17 (2021)
Volume Volume 16 (2020)
Volume Volume 15 (2019)
Volume Volume 14 (2018)
Volume Volume 13 (2017)
Volume Volume 12 (2016)
Chakraborty, R., Darido, C., Alnakli, A., Hu, H., Vickery, K. (2022). A Review on the Dual Role of SOCS3 in Cancer. Research in Oncology, 18(1), 1-9. doi: 10.21608/resoncol.2022.114548.1159
Rajdeep Chakraborty; Charbel Darido; Aziz A. A. Alnakli; Honghua Hu; Karen Vickery. "A Review on the Dual Role of SOCS3 in Cancer". Research in Oncology, 18, 1, 2022, 1-9. doi: 10.21608/resoncol.2022.114548.1159
Chakraborty, R., Darido, C., Alnakli, A., Hu, H., Vickery, K. (2022). 'A Review on the Dual Role of SOCS3 in Cancer', Research in Oncology, 18(1), pp. 1-9. doi: 10.21608/resoncol.2022.114548.1159
Chakraborty, R., Darido, C., Alnakli, A., Hu, H., Vickery, K. A Review on the Dual Role of SOCS3 in Cancer. Research in Oncology, 2022; 18(1): 1-9. doi: 10.21608/resoncol.2022.114548.1159

A Review on the Dual Role of SOCS3 in Cancer

Article 1, Volume 18, Issue 1, June 2022, Page 1-9  XML PDF (249.46 K)
Document Type: Review articles
DOI: 10.21608/resoncol.2022.114548.1159
View on SCiNiTO View on SCiNiTO
Authors
Rajdeep Chakraborty email orcid 1; Charbel Daridoorcid 2, 3; Aziz A. A. Alnakliorcid 1; Honghua Huorcid 1; Karen Vickeryorcid 1
1Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia
2Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia
3Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3000, Australia
Abstract
Background: Aberrant proliferation is a hallmark of cancer. Cellular proliferation mechanisms and various cytokines contribute to the progression of cancer. The tumor suppressor protein Suppressor of Cytokine Signalling 3 (SOCS3), which acts via the JAK/STAT pathway, have a role in the progression of cancer.
Aim: To explore the role of SOCS3 in all the hallmarks of cancer. To exhibit SOCS3 action on proliferation pathways and immune aspect affecting cancer progression.
Methods: The PubMed database was searched using the keywords proliferation, SOCS3, JAK/STAT, interleukins, and tumor suppressor. Articles relevant to SOCS3 were considered for this review.
Results: In this review, we have illustrated the dual action of SOCS3, which inhibits various proliferative mechanisms and affects certain interleukins that counterbalance the progression of cancer. In addition, SOCS3 affects all the hallmarks of cancer.
Conclusion: We hope that this review will stimulate further investigation of SOCS3, which has the potential to become a new target for the pharmacological treatment of various cancers in the future.
Keywords
Cancer; SOCS3; JAK/STAT; Interleukins; Proliferation
Statistics
Article View: 630
PDF Download: 642
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.